Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications
Integration of spatial single-cell proteomics and spatial metabolomics reveals tumor microenvironment predictive of immunotherapy response in mucosal melanoma.
Journal: bioRxiv : the preprint server for biology
Published: May 07, 2026
Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.
Journal: Annals of surgical oncology
Published: April 24, 2026
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical Trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 26, 2026
Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 26, 2026
Immune hallmarks of recurrent immune checkpoint inhibitor-mediated inflammatory arthritis.
Journal: Cancer immunology research
Published: December 23, 2025
Editor's Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Journal: Cancer discovery
Published: September 17, 2025
Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence.
Journal: Kidney international reports
Published: September 16, 2025
Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study.
Journal: Cancer discovery
Published: September 08, 2025
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma.
Journal: Oncoimmunology
Published: August 15, 2025
Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.
Journal: Annals of surgical oncology
Published: August 01, 2025
Adjuvant therapy in mucosal melanoma: a single-center experience and review of the literature.
Journal: Melanoma research
Published: July 15, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 10, 2025
Last Updated: 09/26/2026